On Wednesday, 10x Genomics Inc (NASDAQ:TXG) reported a fourth-quarter EPS loss of $(0.40), missing the consensus estimate of ...

Morgan Stanley analyst Tejas Savant maintained a Buy rating on 10x Genomics (TXG – Research Report) today and set a price target of $26.00. The company’s shares closed yesterday at $11.94.

Biotech company 10x Genomics (NASDAQ:TXG) will be reporting earnings tomorrow after market hours. Here’s what to look for. 10x Genomics missed analysts’ revenue expectations by 5% last quarter ...

The Golf Academy offers guidance on how to make your golfing game even stronger. Here, Major champion Sir Nick Faldo reveals the secrets of good iron game. Ep. 2.

Corey Perrine/Florida Times-Union / USA TODAY NETWORK via Imagn Images The PGA Tour has relaxed some of its rules for media video at tournaments ... covering golf. Before joining SI in October ...

10x Genomics Price Performance Shares of TXG opened at $12.31 on Tuesday. The firm has a market cap of $1.49 billion, a PE ratio of -8.05 and a beta of 1.85. The stock’s fifty day moving average ...

In trading on Monday, shares of 10x Genomics Inc (Symbol: TXG) entered into oversold territory, hitting an RSI reading of 27.9, after changing hands as low as $11.8955 per share. By comparison ...

Volkswagen's duo of hot hatches just got a little more expensive. The automaker released pricing figures for the 2025 Golf GTI and Golf R, both of which see increases compared with their 2024 ...

NASDAQ TXG opened at $12.31 on Thursday. The stock’s 50 day moving average is $14.68 and its 200 day moving average is $17.35. The stock has a market cap of $1.49 billion, a PE ratio of -8.05 ...